Literature DB >> 29557937

Dr. Terry B. Strom, Professor of Medicine and Surgery Harvard Medical School, Boston, MA. USA A Retrospective of a Transplant Visionary, Innovator, and Dedicated Mentor.

Xian C Li1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29557937      PMCID： PMC5863590          DOI： 10.1097/TP.0000000000002084

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  11 in total

Review 1.  T cell death and transplantation tolerance.

Authors:  X C Li; T B Strom; L A Turka; A D Wells
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

2.  Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance.

Authors:  Xin Xiao Zheng; Alberto Sánchez-Fueyo; Masayuki Sho; Christoph Domenig; Mohamed H Sayegh; Terry B Strom
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

Review 3.  Recently discovered T cell subsets cannot keep their commitments.

Authors:  Terry B Strom; Maria Koulmanda
Journal:  J Am Soc Nephrol       Date:  2009-08       Impact factor: 10.121

4.  Specific insulin binding site on T and B lymphocytes as a marker of cell activation.

Authors:  J H Helderman; T B Strom
Journal:  Nature       Date:  1978-07-06       Impact factor: 49.962

5.  Identity and cytotoxic capacity of cells infiltrating renal allografts.

Authors:  T B Strom; N L Tilney; C B Carpenter; G J Busch
Journal:  N Engl J Med       Date:  1975-06-12       Impact factor: 91.245

6.  Heightened intragraft CTL gene expression in acutely rejecting renal allografts.

Authors:  M L Lipman; A C Stevens; T B Strom
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

7.  Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4+ T Cell Dysfunction.

Authors:  Jie Wu; Hedong Zhang; Xiaomin Shi; Xiang Xiao; Yihui Fan; Laurie J Minze; Jin Wang; Rafik M Ghobrial; Jiahong Xia; Roger Sciammas; Xian C Li; Wenhao Chen
Journal:  Immunity       Date:  2017-12-05       Impact factor: 31.745

8.  In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response.

Authors:  Zhigang Fan; Joel A Spencer; Yan Lu; Costas M Pitsillides; Gurbakhshish Singh; Pilhan Kim; Seok H Yun; Vasilis Toxavidis; Terry B Strom; Charles P Lin; Maria Koulmanda
Journal:  Nat Med       Date:  2010-05-23       Impact factor: 53.440

9.  Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

Authors:  B Nashan; R Moore; P Amlot; A G Schmidt; K Abeywickrama; J P Soulillou
Journal:  Lancet       Date:  1997-10-25       Impact factor: 79.321

10.  Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice.

Authors:  R L Kirkman; L V Barrett; G N Gaulton; V E Kelley; A Ythier; T B Strom
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.